Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 14
  • Journal CiteScore: 3.77
  • Journal Impact Factor: 4.09
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer

Primary Central Nervous System Lymphoma: A Critical Review of the Role of Surgery for Resection

Google Scholar citation report
Citations : 1140

Archives in Cancer Research received 1140 citations as per Google Scholar report

Flyer image
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
View More
Share This Page

Using different next generation sequencing technologies to study the role of human papillomavirus integration in the development of cancer

2nd Edition of International Conference on Clinical Oncology and Molecular Diagnostics
June 11- 13, 2018 Dublin, Ireland

David I Smith

Mayo Clinic center, USA

Scientific Tracks Abstracts: Arch Cancer Res

Abstract:

Human papillomavirus (HPV) is involved in the development of cervical cancer and a number of other anogenital cancers. It is also increasingly involved in the development of one type of head and neck cancer, namely oropharyngeal squamous cell carcinoma (OPSCC). One key step in the development of many of these cancers is integration of the HPV viral genome somewhere within the human genome, but it is unclear precisely when this occurs, and the precise role that the integration event plays in cancer development. In order to study the different ways that HPV is involved in the development of OPSCC we have been using different genome sequencing technologies to study the physical status of HPV in this cancer. We have used mate-pair next generation sequencing on the Illumina platform and also whole genome sequencing on the BGI Seq500 sequencing platform. This has enabled us to compare these two platforms for their ability to characterize important physical attributes of this cancer including the site of HPV integration, and the resulting dramatic genomic changes of the HPV integration event. We have also been able to determine genome-wide changes in OPSCC separate from the HPV integration event.

Recent Publications
1. Gao G and Smith D I (2015) Mate-pair sequencing as a powerful clinical tool for the characterization of cancers with a DNA viral etiology. Viruses 7(8):45074528.
2. Gao G and Smith D I (2016) Role of the common fragile sites in cancers with a human papillomavirus etiology. Cytogenetic and Genome Research 150(3-4):217-226.
3. Gao G and Smith D I (2016) Human papillomavirus and the development of different cancers. Cytogenetic and Genome Research 150(3-4):185-193.
4. Gao G and Smith D I (2015) WWOX, large common fragile site genes, and cancer. Experimental Biology and Medicine (Maywood) 240(3):285-295.

Biography :

David I Smith received his PhD in Biochemistry from the University of Wisconsin in Madison in 1978. His first academic position was at Wayne State University School of Medicine and in 1996 he moved to the Mayo Clinic as a Professor in the Department of Laboratory Medicine and Pathology. He is also the Chairman of the Technology Assessment Group for the Mayo Clinic Center for Individualized Medicine. His laboratory utilizes next generation sequencing to study the different ways that human papillomavirus can cancer in different tissues. His group also studies the common fragile sites which are regions of profound instability found in all individuals.

Email:smith.david@mayo.edu
 

PDF HTML